Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis c virus infected patients. Results in real clinical practice

  1. Margusino-Framiñán, L.
  2. Cid-Silva, P.
  3. Mena-Decea, Á.
  4. Rodríguez-Osorio, I.
  5. Pernas-Souto, B.
  6. Delgado-Blanco, M.
  7. Pertega-Díaz, S.
  8. Martín-Herranz, I.
  9. Castro-Iglesias, Á.
Journal:
Revista Espanola de Quimioterapia

ISSN: 1988-9518 0214-3429

Year of publication: 2019

Volume: 32

Issue: 2

Pages: 137-144

Type: Article